{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-24-033856","form_type":"8-K","ticker":"NKTR","cik":"0000906709","company_name":"NEKTAR THERAPEUTICS","filed_at":"2024-04-17T23:59:59+00:00","discovered_at":"2026-05-14T18:03:22.394010+00:00","generated_at":"2026-06-03T21:59:43.747106+00:00","sec_items":["8.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Nektar Therapeutics regains Nasdaq minimum bid price compliance","bullets":["Received Nasdaq notice on April 17, 2024, confirming compliance regained as of April 16, 2024.","Common stock closing bid price met $1.00 minimum for 10 consecutive business days.","Stock had been non-compliant since May 2023 and transferred to Nasdaq Capital Market in November 2023.","Additional 180-day extension had been granted until May 20, 2024.","Continued listing on Nasdaq Capital Market is now secure."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-24-033856","json":"https://secwatch.observer/filing/0001213900-24-033856.json","markdown":"https://secwatch.observer/filing/0001213900-24-033856.md","text":"https://secwatch.observer/filing/0001213900-24-033856.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/906709/000121390024033856/0001213900-24-033856-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/906709/000121390024033856/ea0204090-8k_nektar.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-03T21:59:43.747106+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}